Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

The Serine Protease Matriptase Acts As a Tumour Suppressor in Multiple Myeloma

Ida Steiro, Pegah Abdollahi, PhD, Magne Børset, MD PhD, Tobias S. Slørdahl, MD PhD

Blood (2020) 136 (Supplement 1): 14.

https://doi.org/10.1182/blood-2020-140229

Published: 2020

Journal Articles

PRL-3 Mediates Survival of Primary Myeloma Cells

Torstein Baade Rø, MD PhD, Tobias Schmidt Slordahl, MD PhD, Pegah Abdollahi, MSc, Esten Vansemb, Lars Hagen, PhD, Katarzyna Anna Baranowska, MD, Kristine Misund, PhD, Geir Slupphaug, PhD, Magne Borset, MD PhD

Blood (2014) 124 (21): 2040.

https://doi.org/10.1182/blood.V124.21.2040.2040

Published: 2014

Journal Articles

PRL-3 Regulates Myeloma Cell Survival, Proliferation, Adhesion and Migration

Tobias Schmidt Slordahl, MD, Kristine Misund, PhD, Torstein Baade Ro, MD, PhD, Magne Borset, MD, PhD

Blood (2012) 120 (21): 1321.

https://doi.org/10.1182/blood.V120.21.1321.1321

Published: 2012

Journal Articles

A Method for Measurement of Drug Sensitivity of Myeloma Cells Co-Cultured with Bone Marrow Stromal Cells

Kristine Misund, PhD, Katarzyna Anna Baranowska, MD, Toril Holien, PhD, Christoph Rampa, MSc, Dionne Klein, PhD, Magne Børset, MD, PhD, Anders Waage, MD, PhD, Anders Sundan, PhD

Blood (2012) 120 (21): 1373.

https://doi.org/10.1182/blood.V120.21.1373.1373

Published: 2012

Journal Articles

Serum/Glucocorticoid-Regulated Kinase 1 (SGK1) Is a Prominent Target Gene of the Transcriptional Response to Cytokines In Multiple Myeloma and Supports the Growth of Myeloma Cells

Unn-Merete Fagerli, MD, PhD, Thorsten Stühmer, PhD, Toril Holien, Randi Utne Holt, PhD, Ove Bruland, PhD, Manik Chatterjee, MD, John Shaughnessy, Jr, PhD, Stephan Mathas, MD, Anders Sundan, MD, Ralf C Bargou, MD, Bernd Dörken, MD, Magne Borset, MD, PhD, Martin Janz, MD

Blood (2010) 116 (21): 1915.

https://doi.org/10.1182/blood.V116.21.1915.1915

Published: 2010

Journal Articles

OH-2, a Hyperdiploid Myeloma Cell Line without An IGH Translocation, Has a Complex Translocation Juxtaposing MYC near MAFB and the IGK Locus

Thea Kristin Våtsveen, Erming Tian, Stine H Kresse, Leonardo A Meza-zepeda, Ana Gabrea, Hong Yan Dai, Michael Kuehl, MD, Anders Sundan, Magne Borset, MD, PhD

Blood (2008) 112 (11): 2736.

https://doi.org/10.1182/blood.V112.11.2736.2736

Published: 2008

Journal Articles

Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells

Unn-Merete Fagerli, Randi U. Holt, Toril Holien, Thea K. Vaatsveen, Fenghuang Zhan, Kjartan W. Egeberg, Bart Barlogie, Anders Waage, Harald Aarset, Hong Yan Dai, John D. Shaughnessy, Jr, Anders Sundan, Magne Børset

Blood (2008) 111 (2): 806–815.

https://doi.org/10.1182/blood-2007-07-101139

Published: 2008

Journal Articles

IL-6 and IGF-1 Act in Synergy with HGF in Myeloma Cells by Modulating the Ras-MAPK Pathway.

Håkon Hov, MD, Erming Tian, BS, Anders Waage, MD, PhD, Magne Børset, MD, PhD, Anders Sundan, PhD

Blood (2007) 110 (11): 4793.

https://doi.org/10.1182/blood.V110.11.4793.4793

Published: 2007

Journal Articles

HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myeloma

Therese Standal, Niels Abildgaard, Unn-Merete Fagerli, Berit Stordal, Øyvind Hjertner, Magne Borset, Anders Sundan

Blood (2006) 109 (7): 3024–3030.

https://doi.org/10.1182/blood-2006-07-034884

Published: 2006

Includes: Supplemental data

Journal Articles

Multiple Myeloma: Interleukin-15 Antagonizes Bone Morphogenetic Protein-Induced Apoptosis and Growth Inhibition.

Magne Rekvig, Anne-Tove Brenne, Torstein Baade Ro, Anders Waage, Magne Borset, Anders Sundan

Blood (2006) 108 (11): 3444.

https://doi.org/10.1182/blood.V108.11.3444.3444

Published: 2006

Journal Articles

HGF Inhibits BMP-Induced Osteoblastogenesis: Implications for the Bone Disease in Multiple Myeloma.

Therese Standal, Niels Abildgaard, Unn-Merete Fagerli, Berit Stordal, Oyvind Hjertner, Magne Borset, Anders Sundan

Blood (2006) 108 (11): 3451.

https://doi.org/10.1182/blood.V108.11.3451.3451

Published: 2006

Journal Articles

IL-6, IGF-1 and IL-21 Act in Synergy with HGF in Myeloma Cells by Inducing the HGF-Receptor c-Met.

Håkon Hov, MD, Unn-Merethe Fagerli, MD, Erming Tian, BS, Anders Waage, MD, PhD, Magne Borset, MD, PhD, Anders Sundan, PhD

Blood (2006) 108 (11): 3438.

https://doi.org/10.1182/blood.V108.11.3438.3438

Published: 2006

Journal Articles

Induction of Cyclin D1 by HGF, IGF-1 and IL-6 in a Human Myeloma Cell Line with a t(11:14) Translocation.

Håkon Hov, MD, Thea K. Våtsveen, Anders Waage, MD,PhD, Anders Sundan, MD,PhD, Magne Borset, MD,PhD

Blood (2006) 108 (11): 5055.

https://doi.org/10.1182/blood.V108.11.5055.5055

Published: 2006

Journal Articles

Bmps(Bone Morphogenetic Proteins) Inhibit Growth in Multiple Myeloma Cells by p53 Activation.

Anders Sundan, PhD, Torstein B. Ro, MD, Janne Bonhorst, PhD, Anders Waage, MD, PhD, Magne Borset, MD, PhD

Blood (2004) 104 (11): 3354.

https://doi.org/10.1182/blood.V104.11.3354.3354

Published: 2004

Journal Articles

A Selective Inhibitor of c-Met Blocks an Autocrine HGF Growth Loop in ANBL-6 Cells and Prevents Migration and Adhesion of Myeloma Cells.

Magne Borset, M.D., Ph.D., Hakon Hov, M.D., Randi U. Holt, M.Sc., Torstein B. Ro, M.D., Unn-Merete Fagerli, M.D., Henrik Hjorth-Hansen, M.D., Ph.D., Vadim Baykov, M.D., Ph.D., James G. Christensen, Ph.D., Anders Waage, M.D., Ph.D., Anders Sundan, Ph.D.

Blood (2004) 104 (11): 2358.

https://doi.org/10.1182/blood.V104.11.2358.2358

Published: 2004

Journal Articles

Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor

Therese Standal, Magne Borset, Stig Lenhoff, Finn Wisloff, Berit Stordal, Anders Sundan, Anders Waage, Carina Seidel

Blood (2002) 100 (12): 3925–3929.

https://doi.org/10.1182/blood-2002-05-1406

Published: 2002

Journal Articles

Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells

Therese Standal, Carina Seidel, Øyvind Hjertner, Torben Plesner, Ralph D. Sanderson, Anders Waage, Magne Borset, Anders Sundan

Blood (2002) 100 (8): 3002–3007.

https://doi.org/10.1182/blood-2002-04-1190

Published: 2002

Journal Articles

Interleukin-21 is a growth and survival factor for human myeloma cells

Anne-Tove Brenne, Torstein Baade Ro, Anders Waage, Anders Sundan, Magne Borset, Henrik Hjorth-Hansen

Blood (2002) 99 (10): 3756–3762.

https://doi.org/10.1182/blood.V99.10.3756

Published: 2002

Journal Articles

Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease

Carina Seidel, Øyvind Hjertner, Niels Abildgaard, Lene Heickendorff, Martin Hjorth, Jan Westin, Johan Lanng Nielsen, Henrik Hjorth-Hansen, Anders Waage, Anders Sundan, Magne Børset

Blood (2001) 98 (7): 2269–2271.

https://doi.org/10.1182/blood.V98.7.2269

Published: 2001

Journal Articles

High levels of soluble syndecan-1 in myeloma-derived bone marrow: modulation of hepatocyte growth factor activity

Carina Seidel, Magne Børset, Øyvind Hjertner, Dianjun Cao, Niels Abildgaard, Henrik Hjorth-Hansen, Ralph D. Sanderson, Anders Waage, Anders Sundan

Blood (2000) 96 (9): 3139–3146.

https://doi.org/10.1182/blood.V96.9.3139

Published: 2000

NARROW

The Serine Protease Matriptase Acts As a Tumour Suppressor in Multiple Myeloma

PRL-3 Mediates Survival of Primary Myeloma Cells

PRL-3 Regulates Myeloma Cell Survival, Proliferation, Adhesion and Migration

A Method for Measurement of Drug Sensitivity of Myeloma Cells Co-Cultured with Bone Marrow Stromal Cells

Serum/Glucocorticoid-Regulated Kinase 1 (SGK1) Is a Prominent Target Gene of the Transcriptional Response to Cytokines In Multiple Myeloma and Supports the Growth of Myeloma Cells

OH-2, a Hyperdiploid Myeloma Cell Line without An IGH Translocation, Has a Complex Translocation Juxtaposing MYC near MAFB and the IGK Locus

Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells

IL-6 and IGF-1 Act in Synergy with HGF in Myeloma Cells by Modulating the Ras-MAPK Pathway.

HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myeloma

Multiple Myeloma: Interleukin-15 Antagonizes Bone Morphogenetic Protein-Induced Apoptosis and Growth Inhibition.

HGF Inhibits BMP-Induced Osteoblastogenesis: Implications for the Bone Disease in Multiple Myeloma.

IL-6, IGF-1 and IL-21 Act in Synergy with HGF in Myeloma Cells by Inducing the HGF-Receptor c-Met.

Induction of Cyclin D1 by HGF, IGF-1 and IL-6 in a Human Myeloma Cell Line with a t(11:14) Translocation.

Bmps(Bone Morphogenetic Proteins) Inhibit Growth in Multiple Myeloma Cells by p53 Activation.

A Selective Inhibitor of c-Met Blocks an Autocrine HGF Growth Loop in ANBL-6 Cells and Prevents Migration and Adhesion of Myeloma Cells.

Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor

Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells

Interleukin-21 is a growth and survival factor for human myeloma cells

Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease

High levels of soluble syndecan-1 in myeloma-derived bone marrow: modulation of hepatocyte growth factor activity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only